The first new pharmaceutical drug invented and developed for an untreated disorder by any Australian company has received regulatory approval from the European Medicines Agency (EMA). SCENESSE® (afamelanotide 16mg) treats

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In